Roles of nitric oxide and nitric oxide synthases in tissue damage of obstructed ureters in rats

Scandinavian Journal of Urology and Nephrology

Volumn 39, Issue 3, 2005, Pages 187-193

  Chuang, Yen Hwang ^a   Chuang, Wan Long ^a   Huang, Shu Pin ^a   Huang, Chun Hsiung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Nitric oxide; Nitric oxide synthases; Nitrotyrosine; Obstructive uropathy; Ureter

Indexed keywords

3 NITROTYROSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MUSCLE HYPERTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; TISSUE INJURY; URETER; URETER INJURY; URETER LIGATION; URETER OBSTRUCTION;

ANIMALS; FEMALE; MUSCLE, SMOOTH; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TYROSINE; URETERAL OBSTRUCTION;

EID: 22144431607     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/99365590510031110     Document Type: Article

References (38)

1. Gulmi FA, Felsen D, Vaughan ED. The pathophysiology of urinary tract obstruction. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's urology, vol. 1. Philadelphia, PA: WB Saunders; 2002. p. 411-56.
2. Chuang YH, Chuang WL, Huang SP, Liu KM, Huang CH. The temporal relationship between the severity of hydro-ureter and the dynamic changes of obstructed ureters in a rat model. Br J Urol 1995;76:303-10.
3. Leahy AL, Ryan PC, McEnttee GM, Nelson AC, Fitzpatrick JM. Renal injury and recovery in partial ureteric obstruction. J Urol 1989;142:199-203.
4. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
5. Dudek RR, Wildhirt S, Conforto A, Pinto V, Suzuki H, Winder S, et al. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit. Biochem Biophys Res Commun 1994;205:1671-80.
6. Corbett SR, Hukkanen M, Batten M, McCarthy ID, Polak JM, Hughes SPF. Nitric oxide: fracture repair. J Bone Joint Surg Br 1999;81:531-7.
7. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in model of focal ischemia. Stroke 1997;28:1283-8.
8. Haenderler J, Zieher AM, Dimmelet S. Nitric oxide and apoptosis. Vitam Horm 1999;57:49-77.
9. Saxena D, Purohit SB, Kumar GP, Laloraya M. Increased appearance of inducible nitric oxide synthase in the uterus and embryo at implantation. Nitric Oxide 2000;221:384-91.
10. Billiar TR. Nitric oxide. Novel biology with clinical relevance. Ann Surg 1995;4:339-49.
11. Khorram O, Garthwaite M, Magness RR. Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women. J Clin Endocrinol Metab 1999;84:2226-32.
12. Perreault M, Dombrowski L, Marette A. Mechanism of nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats. Diabetologia 2000;43:427-37.
13. Fukuchi M, Hussain SN, Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthase in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy. Circulation 1998;98:132-9.
14. Yamashita J, Ogata M, Itoh M, Yamasowa H, Shimeda Y, Takaoka M, et al. Role of nitric oxide in the renal protective effects of ischemic preconditioning. J Cardiovasc Pharmacol 2003;43:419-27.
15. Southan GJ, Szabo C. Selective pharmacological inhibitor of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996;51:383-94.
16. Nathan C, Xie Q-W. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
17. Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide synthase. Am J Physiol 1994;266: E829-39.
18. Stief CG, Uckert S, Truss MC, Becker AJ, Machtens S, Jonas U. A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro. Urol Res 1996;24:333-7.
19. Iselin CE, Aim P, Schaad NC, Larsson B, Graber P, Andersson KE. Nitric oxide inhibits contraction of isolated pig ureteral smooth muscle. J Urol 1996;155:763-7.
20. Hernandez M, Prieto D, Orensanz LM, Barahona MV, Jimenez-Cidre M, Rivera L, et al. Involvement of a glibenclamide-sensitive mechanism in the nitrergic neurotransmission of the pig intravesical ureter. Br J Pharmacol 1997;120:609-16.
21. Osei SY, Anima RS, Febry ME, Nagel RL, Bank N. Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: the effect of hypoxia. Blood 1996;88:3583-8.
22. Chuang YH, Chuang WL, Liu KM, Chen SS, Huang CH. Tissue damage and regeneration of the ureteric smooth muscle in rat with obstructive uropathy. Br J Urol 1998;2:261-6.
23. Chuang YH, Chuang WL, Chen SS, Huang CH. Expression of transforming growth factor-β1 and its receptors related to the ureteric fibrosis in a rat model of obstructive uropathy. J Urol 2000;163:1298-303.
24. Chuang YH, Chuang WL, Huang CH. Myocyte apoptosis in the pathogenesis of ureteral damage in rats with obstructive uropathy. Urology 2001;58:463-70.
25. Chuang Y-H, Chuang W-L, Huang S-P, Huang C-H. Expression of epidermal growth factor, basic fibroblast growth factor and insulin growth factor-1 and relation to myocyte regeneration of obstructed ureters in rats. Scand J Urol Nephrol 2005;39:7-14.
26. Hsu SM, Raine L. The use of avidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: Delellis RA, editor. Advances in immunohistochemistry. Chicago, IL: Year Book Medical; 1984. p. 31-43.
27. Le Cras TD, Xue C, Rengasamy A, Johns RA. Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung. Am J Physiol 1996;270:L164-70.
28. Roret-Benzineb P, Eddahibi S, Raffestin B, Laplace M, Depend S, Adnot S, et al. Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia. J Mol Cell Cardiol 1999;31:1697-708.
29. Le Cras TD, Tyler RC, Horan MP, Morris KG, Tuder RM, McMurtry IF, et al. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung. J Clin Invest 1998;101:795-801.
30. Chang B, Mathew R, Palmer LS, Valderrama E, Trachtman H. Nitric oxide in obstructive uropathy: role of endothelial nitric oxide synthase. J Urol 2002;168:1801-4.
31. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem 1994;375:81-8.
32. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 1999;31:651-69.
33. Chen J, Poppas DP, Vaughan ED, Felsen JD. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction (UUO). J Urol 1998;163(Suppl):83.
34. Felsen D, Schulsinger D, Gross SS, Kim FY, Marion D, Vaughan EDV. Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide. J Urol 2003;169:373-6.
35. Hegarty NJ, Young LS, Kirwan CN, O'Neill AJ, Bouchier-Hayes DM, Sweeney P, et al. Nitric oxide in unilateral ureteral obstruction: effect on regional renal blood flow. Kidney Int 2001;59:1059-65.
36. Morrissey JJ, Ishidoya S, McCracken R, Klahr S. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 1996;7:2202-12.
37. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9.
38. Kim Y-M, Bombeck CA, Billier TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84:253-6.